GlassScriptPhysician profile
Bibiana Steinbauer
NPI 1548527385
$715.32
in general payments reported to CMS, 2019-2025
17 companies · $251 in 2025
The $251 reported for 2025 was more than what 82% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $117 · 2023: $214 · 2024: $133 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $171.83 | 2022-2025 | Entyvio, Eohilia |
| Madrigal Pharmaceuticals | $120.01 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Biotech, INC. | $83.79 | 2022-2023 | Simponi, Remicade, Simponi Aria |
| Ardelyx, INC. | $54.88 | 2023-2024 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $53.51 | 2023-2025 | Dupixent |
| Qol Medical, LLC | $29.74 | 2023 | Sucraid |
| Aimmune Therapeutics, INC. | $29.55 | 2025 | Zenpep |
| Sandoz INC. | $26.19 | 2025 | Hyrimoz |
| Mylan Institutional INC. | $22.53 | 2023 | Hulio |
| Intercept Pharmaceuticals, INC. | $18.05 | 2023 | Ocaliva |
| Ferring Pharmaceuticals INC. | $18.02 | 2023 | Rebyota |
| Merck Sharp & Dohme LLC | $16.12 | 2024 | Dificid |
| Abbvie INC. | $14.86 | 2024 | |
| Orphalan INC | $14.39 | 2025 | Cuvrior |
| Fresenius Kabi USA, LLC | $14.36 | 2024 | Idacio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $14.10 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bibiana Steinbauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.